Cathie Wood's Favorite Biotech Stock Is Under Pressure Amid Insider Sales And Slow Revenue Growth: Momentum Score Drops Swiss-American biotechnology company, CRISPR Therapeutics AG (NASDAQ: CRS...
#ARKG #ARKK #benzinga #ratings #Biotech #CRSP #Equities #Mid […]
[Original post on benzinga.com]